Nihon Kohden (NHNKY) Expected to Post Earnings on Wednesday

Nihon Kohden (OTCMKTS:NHNKY) is expected to be posting its results after the market closes on Wednesday, August 5th. Analysts expect the company to post earnings of $0.06 per share and revenue of $299.9750 million for the quarter.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings data on Thursday, May 14th. The company reported $0.34 EPS for the quarter, topping analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.46%. The firm had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. On average, analysts expect Nihon Kohden to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Nihon Kohden Price Performance

NHNKY stock opened at $9.92 on Monday. Nihon Kohden has a 1-year low of $8.12 and a 1-year high of $14.21. The firm has a fifty day moving average price of $9.07 and a two-hundred day moving average price of $9.82. The firm has a market cap of $1.67 billion, a price-to-earnings ratio of 16.81 and a beta of 0.39.

Analyst Ratings Changes

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a report on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company. According to MarketBeat, the stock has a consensus rating of “Buy”.

Nihon Kohden Company Profile

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.